Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
Sedat Yilmaz, Ismail Simsek Division of Rheumatology, Gulhane School of Medicine, Ankara, Turkey Abstract: Tocilizumab is a fully humanized monoclonal antibody against interleukin-6 receptors that was approved for the treatment of patients with rheumatoid arthritis (RA). Several lines of evidence, o...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-10-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/early-intervention-in-the-treatment-of-rheumatoid-arthritis-focus-on-t-a14796 |